Clinical Trial Update: A 5 Year Follow-up of Patients Who Were Previously Enrolled Into an Advagraf Trial Following a Liver or Kidney Transplant

View source ↗

Summary

Five-year follow-up data from patients previously enrolled in an Advagraf tacrolimus trial after liver or kidney transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation
• Liver Transplantation

Drugs mentioned

• Advagraf (tacrolimus)

Snippet

Sponsor: Astellas Pharma Europe Ltd. | Conditions: Liver Transplant, Kidney Transplant | Status: COMPLETED